Global Parenteral Nutrition Report Thumbnail

Global Parenteral Nutrition Market by Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals), By Application (Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-634
  • Author: Up Market Research
  • Rating: 4.7
  • Total Reviews: 64
  • No. Of Pages: 211
  • Format:
  • Pub. Date: 2021-03-01
  • Share:

Parenteral nutrition is a form of nutritional support that delivers nutrients, such as protein, fat, and carbohydrate, to the body through a tube directly into the stomach or small intestine. The global parenteral nutrition market is projected to reach USD 7.1 billion by 2028 from USD 5.6 billion in 2018 at a CAGR of 4.8%. The increasing prevalence of chronic diseases coupled with the rise in the adoption rate of minimally invasive surgical procedures is expected to drive growth over the forecast period.

Parenteral nutrition is a form of nutritional support. Nutrients are administered intravenously, bypassing the digestive tract. Parenteral nutrition provides complete and balanced nutrients for patients who have failed to maintain their weight or whose gastrointestinal absorptive capacity has been reduced due to intestinal disease or short bowel syndrome.

The major types of nutrients given are carbohydrates, parenteral lipid emulsion, single-dose amino acid solutions, trace elements, and vitamins and minerals. Parenteral nutrition provides these in a balanced ratio to meet the increased requirements for specific essential nutrients while minimizing metabolic imbalances that can occur when too many calories or protein are ingested orally.

On the basis of type, the global parenteral nutrition market is segmented into Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals.


Carbohydrates provide energy through their breakdown into glucose by the liver without stimulation from insulin from other sources such as food. The primary source of carbohydrate is dextrose which has been associated with an increase in mortality rates due to hyperglycemia (increased blood sugar levels).

Carbohydrates play an important role in energy metabolism by being oxidized into molecules that can produce ATP (adenosine triphosphate). The use of carbohydrate-containing fluids has been reported in patients receiving radiation treatment because it provides high levels of glucose without nutrient overload from fat calories which would cause hyperlipidemia.

Parenteral Lipid Emulsions

These contain various proportions of triglycerides, phospholipids, and cholesterol in an aqueous solution. These are used to treat hypoproteinemia (low levels of protein in the blood) or if intravenous therapy is not tolerated by the individual due to hypersensitivity reaction.

PLEs contain a mixture of lipids including long-chain triglycerides, medium-chain triglycerides, and free fatty acids with each type having different effects on cholesterol levels in the blood when given intravenously. These may also include phospholipids which provide protection against infections since they form protective barriers at sites where bacteria often enter into tissues.

Parenteral lipid emulsions are used in the treatment of patients with malabsorption syndromes, pancreatitis, and other conditions with fat malabsorption.

Single-Dose Amino Acids Solutions

Single-dose amino acid solutions contain a single source of protein such as soy or whey isomaltase hydrolysates to provide essential arginine for growth hormone secretion which may be deficient from prolonged starvation. Trace elements have been reported to prevent anorexia by creating a sense of fullness and preventing wasting by maintaining muscle mass. Vitamins and minerals are used to correct deficiencies caused by malnutrition resulting from inadequate dietary intake due to disease-induced changes in taste perception, appetite suppression, or swallowing difficulties.

This provides essential amino acids which cannot be synthesized by humans such as arginine, glutamine, and glycine. Single-dose solutions can also provide nutritional support for acute hepatic failure where oral intake is not possible because there may be a risk of infection from absorption through the damaged intestinal lining.

Trace Elements

Trace elements include iron, copper-zinc, and iodine which are required minerals that cannot be obtained from food sources. Trace elements are essential for the production of red blood cells, maintenance of the immune system, and healthy bones.

Vitamins & Minerals

Vitamins are essential organic substances that cannot be synthesized by the human body and must be consumed through diet. The deficiency of vitamins can lead to dehydration, fatigue, anemia, and other complications such as heart problems or mental retardation in children. Vitamins such as A (as retinol palmitate), D and K may be administered in PN solutions to meet requirements when dietary intake is inadequate or unavailable. Vitamin C may also be added if there is a lack of adequate food sources available to provide this vitamin.

Minerals are inorganic substances that cannot be synthesized by the human body and must also be consumed through diet. Deficiency of minerals can lead to anemia, fatigue, weakness, or mental retardation among other complications such as heart problems or bone diseases. Minerals may enter PN solutions either in organic form (e.g., calcium) or in trace amounts for nutritional purposes only without causing any adverse effects on patient outcomes (e.g., copper).

On the basis of application, the global parenteral nutrition market is segmented into Premature Infants, Neonates, And Children(N&C), Geriatrics, Chronic Disease Patients (D).

Premature Infants

Premature infants are typically born more than three weeks before their due date. They require special health care services to keep them healthy and strong, including medical treatment in the hospital setting which includes intravenous feedings or parenteral nutrition (PN). It is an important source of calories for premature babies who cannot yet handle solid foods by mouth because this type of food provides nutrients that support growth and development. PN can also be used as a "bridge" method when transitioning newborns from milk-only feeding to a combination with other solids.

For premature infants, parenteral nutrition is most often administered through a central venous catheter. Central veins are typically more accessible than peripheral and smaller in diameter so they can provide better intravenous flow rates. The term ‘parenteral’ means by or through the skin but this technique bypasses first passing through the intestinal tract. On the other hand, parenteral nutrition for neonates and children is given via peripheral vein (e.g., intravenous or subcutaneous) because it passes through the intestine first before reaching the bloodstream.

Neonates, And Children(N&C)

The application of parenteral nutrition for Neonates, And Children(N&C) is to provide them with the essential nutrients needed in order to grow. This type of nutritional support can be given through either an intravenous or a tube feeding method and it contains all essentials for growth like carbohydrates, protein, vitamins minerals, and more.

Neonates are one of the most susceptible categories to develop a metabolic disorder. Inadequate nutrition at this stage can lead to impaired growth and development, which in turn might affect their cognitive skills as well as bone integrity. Moreover, neonatal parenteral nutrition also helps premature babies who have difficulties digesting food because they do not have the necessary enzymes.


Geriatric patients may need parenteral nutrition when they cannot get enough nutrients through diet. Parenteral nutrition provides fluids, electrolytes, and glucose in high concentrations that are not tolerated by the human body. It is sometimes necessary for these types of patients because if their intestines don't work properly they won't be able to digest food into usable nutrients or absorb them sufficiently from the small intestine.

Chronic Disease Patients

The use of parenteral nutrition has been proven effective for chronic disease patients because it can help stimulate gut motility via its action on gastrointestinal hormones; this helps facilitate digestion. In addition, enteral feedings have known risks associated with them; parenteral nutrition can be used for patients with an intolerance to enteral feedings.

On the basis of region, the global parenteral nutrition market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the largest market for parenteral nutrition owing to the high prevalence of chronic diseases among the geriatric population in this region. The U.S., China, and Japan account for a significant growth rate in the North American parenteral nutrition market owing to a higher number of premature infants, neonatal and pediatric patients with nutritional deficiency cases. According to the World Health Organization (WHO), India has witnessed an increase in malnutrition rates due to a declining economy and lack of awareness about good diet practices leading to poor patient compliance towards oral intake as a result. Growth prospects are limited on account of stringent regulations such as Global Food Safety Initiative (GFSI) certification, which restricts imports from countries that do not comply with these standards.

Growth Factors

The growth of the market can be attributed in part due to factors such as favorable reimbursement scenario for hospitals and manufacturers providing these products, increasing incidence rate of chronic diseases among adults with infections like HIV/AIDS or cancer, rising geriatric population base resulting from an overall increase in life expectancy, rise in a number of premature infants who are on ventilators requiring intravenous feeding and continuous need for infusion solutions that enhance nutritional status.

Up Market Research published a new report titled “Parenteral Nutrition Market research report which is segmented by Types (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals), By Applications (Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients), By Players/Companies Baxter International, Hospira, B. Braun Melsungen, Grifols International, Fresenius Kabi, Otsuka Pharmaceutical Factory, Actavis, Sichuan Kelun Pharmaceutical”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report Attributes Report Details
Report Title Parenteral Nutrition Market Research Report
By Type Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals
By Application Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients
By Companies Baxter International, Hospira, B. Braun Melsungen, Grifols International, Fresenius Kabi, Otsuka Pharmaceutical Factory, Actavis, Sichuan Kelun Pharmaceutical
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2020
Historical Year 2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year 2028
Number of Pages 211
Number of Tables & Figures 148
Customization Available Yes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Parenteral Nutrition Industry Outlook

Global Parenteral Nutrition Market Report Segments:

The market is segmented by Type Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals and By Application Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients.


Some of the companies that are profiled in this report are:

  1. Baxter International
  2. Hospira
  3. B. Braun Melsungen
  4. Grifols International
  5. Fresenius Kabi
  6. Otsuka Pharmaceutical Factory
  7. Actavis
  8. Sichuan Kelun Pharmaceutical

Parenteral Nutrition Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Parenteral Nutrition Market

Overview of the regional outlook of the Parenteral Nutrition Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Parenteral Nutrition Market Overview

Highlights of The Parenteral Nutrition Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Parenteral Nutrition Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Carbohydrates

                2. Parenteral Lipid Emulsion

                3. Single Dose Amino Acid Solution

                4. Trace Elements

                5. Vitamins and Minerals

       7. By Application:

                1. Premature Infants, Neonates and Children

                2. Geriatrics

                3. Chronic Disease Patients

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Parenteral Nutrition Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Parenteral Nutrition Market Statistics

Reasons to Purchase the Parenteral Nutrition Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Parenteral Nutrition Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Parenteral Nutrition Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Parenteral Nutrition Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Parenteral Nutrition Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Parenteral Nutrition Market Size & Forecast, 2018-2028 
      4.5.1 Parenteral Nutrition Market Size and Y-o-Y Growth 
      4.5.2 Parenteral Nutrition Market Absolute $ Opportunity 

Chapter 5 Global Parenteral Nutrition Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Parenteral Nutrition Market Size Forecast by Type
      5.2.1 Carbohydrates
      5.2.2 Parenteral Lipid Emulsion
      5.2.3 Single Dose Amino Acid Solution
      5.2.4 Trace Elements
      5.2.5 Vitamins and Minerals
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Parenteral Nutrition Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Parenteral Nutrition Market Size Forecast by Applications
      6.2.1 Premature Infants
      6.2.2  Neonates and Children
      6.2.3 Geriatrics
      6.2.4 Chronic Disease Patients
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Parenteral Nutrition Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Parenteral Nutrition Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Parenteral Nutrition Analysis and Forecast
   9.1 Introduction
   9.2 North America Parenteral Nutrition Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Parenteral Nutrition Market Size Forecast by Type
      9.6.1 Carbohydrates
      9.6.2 Parenteral Lipid Emulsion
      9.6.3 Single Dose Amino Acid Solution
      9.6.4 Trace Elements
      9.6.5 Vitamins and Minerals
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Parenteral Nutrition Market Size Forecast by Applications
      9.10.1 Premature Infants
      9.10.2  Neonates and Children
      9.10.3 Geriatrics
      9.10.4 Chronic Disease Patients
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Parenteral Nutrition Analysis and Forecast
   10.1 Introduction
   10.2 Europe Parenteral Nutrition Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Parenteral Nutrition Market Size Forecast by Type
      10.6.1 Carbohydrates
      10.6.2 Parenteral Lipid Emulsion
      10.6.3 Single Dose Amino Acid Solution
      10.6.4 Trace Elements
      10.6.5 Vitamins and Minerals
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Parenteral Nutrition Market Size Forecast by Applications
      10.10.1 Premature Infants
      10.10.2  Neonates and Children
      10.10.3 Geriatrics
      10.10.4 Chronic Disease Patients
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Parenteral Nutrition Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Parenteral Nutrition Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Parenteral Nutrition Market Size Forecast by Type
      11.6.1 Carbohydrates
      11.6.2 Parenteral Lipid Emulsion
      11.6.3 Single Dose Amino Acid Solution
      11.6.4 Trace Elements
      11.6.5 Vitamins and Minerals
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Parenteral Nutrition Market Size Forecast by Applications
      11.10.1 Premature Infants
      11.10.2  Neonates and Children
      11.10.3 Geriatrics
      11.10.4 Chronic Disease Patients
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Parenteral Nutrition Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Parenteral Nutrition Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Parenteral Nutrition Market Size Forecast by Type
      12.6.1 Carbohydrates
      12.6.2 Parenteral Lipid Emulsion
      12.6.3 Single Dose Amino Acid Solution
      12.6.4 Trace Elements
      12.6.5 Vitamins and Minerals
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Parenteral Nutrition Market Size Forecast by Applications
      12.10.1 Premature Infants
      12.10.2  Neonates and Children
      12.10.3 Geriatrics
      12.10.4 Chronic Disease Patients
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Parenteral Nutrition Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Parenteral Nutrition Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Parenteral Nutrition Market Size Forecast by Type
      13.6.1 Carbohydrates
      13.6.2 Parenteral Lipid Emulsion
      13.6.3 Single Dose Amino Acid Solution
      13.6.4 Trace Elements
      13.6.5 Vitamins and Minerals
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Parenteral Nutrition Market Size Forecast by Applications
      13.10.1 Premature Infants
      13.10.2  Neonates and Children
      13.10.3 Geriatrics
      13.10.4 Chronic Disease Patients
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Parenteral Nutrition Market: Competitive Dashboard
   14.2 Global Parenteral Nutrition Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Baxter International
      14.3.2 Hospira
      14.3.3 B. Braun Melsungen
      14.3.4 Grifols International
      14.3.5 Fresenius Kabi
      14.3.6 Otsuka Pharmaceutical Factory
      14.3.7 Actavis
      14.3.8 Sichuan Kelun Pharmaceutical
Segments Covered in the Report
The global Parenteral Nutrition market has been segmented based on

By Types
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins and Minerals
By Applications
  • Premature Infants, Neonates and Children
  • Geriatrics
  • Chronic Disease Patients
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Baxter International
  • Hospira
  • B. Braun Melsungen
  • Grifols International
  • Fresenius Kabi
  • Otsuka Pharmaceutical Factory
  • Actavis
  • Sichuan Kelun Pharmaceutical

Buy Report